Strong, sustained hepatocellular proliferation precedes hepatocarcinogenesis in hepatitis B surface antigen transgenic mice
- PMID: 7875658
Strong, sustained hepatocellular proliferation precedes hepatocarcinogenesis in hepatitis B surface antigen transgenic mice
Abstract
Hepatocyte turnover rates were studied in two lineages of transgenic mice that overproduce the hepatitis B virus (HBV) large envelope protein and retain filamentous hepatitis B surface antigen (HBsAg) particles in the endoplasmic reticulum, resulting in the formation of ground glass hepatocytes. The high producer lineage (50-4) develops a necroinflammatory liver disease that progresses to hepatocellular carcinoma (HCC), whereas the low producer lineage (107-5) displays no histopathologic changes other than ground glass hepatocytes. Bromodeoxyuridine (BrdU)-labeling studies of S-phase hepatocytes provide quantitative evidence for a strong, sustained proliferative response in the hepatocytes in lineage 50-4 that occurs after the onset of hepatocellular injury but long before the development of liver cell tumors. In contrast, the level of hepatocellular proliferation in lineage 107-5 is the same as nontransgenic controls. The findings support the concept that sustained hepatocellular proliferation plays an important role in the development of hepatocellular carcinoma (HCC).
Similar articles
-
Hepatocarcinogenesis due to chronic liver cell injury in hepatitis B virus transgenic mice.Cancer Res. 1990 Jun 1;50(11):3400-7. Cancer Res. 1990. PMID: 1692259
-
Activation of multidrug resistance (P-glycoprotein) mdr3/mdr1a gene during the development of hepatocellular carcinoma in hepatitis B virus transgenic mice.Cell Growth Differ. 1992 Aug;3(8):531-40. Cell Growth Differ. 1992. PMID: 1356418
-
Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage.Carcinogenesis. 2004 Oct;25(10):2023-32. doi: 10.1093/carcin/bgh207. Epub 2004 Jun 3. Carcinogenesis. 2004. PMID: 15180947
-
[Hepatitis and hepatocarcinogenesis in the transgenic mice].Nihon Rinsho. 1993 Feb;51(2):531-5. Nihon Rinsho. 1993. PMID: 8464165 Review. Japanese.
-
Transgenic mouse models of hepatitis B virus-associated hepatocellular carcinoma.Rev Med Virol. 2003 Jul-Aug;13(4):243-53. doi: 10.1002/rmv.392. Rev Med Virol. 2003. PMID: 12820186 Review.
Cited by
-
Aerobic glycolysis supports hepatitis B virus protein synthesis through interaction between viral surface antigen and pyruvate kinase isoform M2.PLoS Pathog. 2021 Mar 15;17(3):e1008866. doi: 10.1371/journal.ppat.1008866. eCollection 2021 Mar. PLoS Pathog. 2021. PMID: 33720996 Free PMC article.
-
Impact of Hepatitis B Virus Genetic Variation, Integration, and Lymphotropism in Antiviral Treatment and Oncogenesis.Microorganisms. 2020 Sep 24;8(10):1470. doi: 10.3390/microorganisms8101470. Microorganisms. 2020. PMID: 32987867 Free PMC article. Review.
-
Hepatitis B virus replication is cell cycle independent during liver regeneration in transgenic mice.J Virol. 1997 Jun;71(6):4804-8. doi: 10.1128/JVI.71.6.4804-4808.1997. J Virol. 1997. PMID: 9151875 Free PMC article.
-
Biological Basis of Differential Susceptibility to Hepatocarcinogenesis among Mouse Strains.J Toxicol Pathol. 2009 Mar;22(1):11-33. doi: 10.1293/tox.22.11. Epub 2009 Apr 6. J Toxicol Pathol. 2009. PMID: 22271974 Free PMC article.
-
Cyclooxygenase-2 expression in hepatocellular carcinoma, cirrhosis and chronic hepatitis in the United States.Dig Dis Sci. 2007 Jan;52(1):220-7. doi: 10.1007/s10620-006-9184-3. Epub 2006 Dec 8. Dig Dis Sci. 2007. PMID: 17160481
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases